Table 3.
M1 | M2 | Estimated diff | Effect size | 95% CI | t (df) | p | |
---|---|---|---|---|---|---|---|
EDE-Q | |||||||
SOT–EOT | 3.5 | 2.5 | − 1.0 | 1.00 | 1.24 to 0.77 | 8.5 (236) | < 0.001 |
EOT–FU | 2.5 | 2.2 | 0.3 | 0.32 | 0.62 to 0.03 | 2.2 (247) | 0.032 |
SOT–FU | 3.5 | 2.2 | 1.3 | 1.32 | 1.64 to 1.01 | 8.4 (128) | < 0.001 |
SDQ | |||||||
SOT–EOT | 17.2 | 15.7 | − 1.45 | − 0.51 | − 2.13 to − 0.76 | − 4.2 (234) | < 0.001 |
EOT–FU | 15.7 | 14.0 | − 1.75 | − 0.61 | − 2.64 to − 0.86 | − 3.9 (243) | < 0.001 |
SOT–FU | 17.2 | 14.0 | − 3.20 | − 1.12 | − 4.17 to − 2.22 | − 6.5 (128) | < 0.001 |
BMI percentile | |||||||
SOT–EOT | 19.7 | 32.7 | 13.1 | 0.91 | 10.02 to 16.11 | − 8.4 (290) | < 0.001 |
EOT–FU | 32.7 | 33.6 | 0.9 | 0.06 | 2.95 to 4.66 | − 0.4 (313) | 0.659 |
SOT–FU | 19.7 | 33.6 | 13.9 | 0.97 | 10.24 to 17.59 | − 7.4 (331) | < 0.001 |
EDE-Q eating disorder examination questionnaire global score, EOT end-of-treatment, FU follow-up, SDQ strengths and difficulties questionnaire total score, SOT start-of-treatment
For BMI percentile, the pairwise comparisons were based on a model without the interaction term included in the LMM